HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kara A Lombardo Selected Research

Kara A Lombardo Research Topics

Disease

11Neoplasms (Cancer)
05/2024 - 01/2016
8Carcinoma (Carcinomatosis)
01/2024 - 01/2018
4Urinary Bladder Neoplasms (Bladder Cancer)
05/2024 - 01/2022
3Bites and Stings (Sting)
12/2023 - 01/2022
2Virus Diseases (Viral Diseases)
10/2023 - 03/2022
2Carcinoma in Situ
01/2021 - 01/2019
2Small Cell Carcinoma
01/2021 - 02/2020
2Prostatic Neoplasms (Prostate Cancer)
01/2020 - 01/2017
2Adenocarcinoma
07/2018 - 01/2017
2Eosinophilic Esophagitis
01/2018 - 10/2017
1Pneumonia (Pneumonitis)
03/2022
1COVID-19
03/2022
1Non-Muscle Invasive Bladder Neoplasms
01/2022
1Adenoid Cystic Carcinoma (Cylindroma)
01/2021
1Sarcoma (Soft Tissue Sarcoma)
10/2018
1Atrophy
01/2018
1Hyperplasia
01/2018
1Gender Dysphoria
01/2018
1Myositis (Idiopathic Inflammatory Myopathies)
10/2017
1Inflammation (Inflammations)
10/2017
1Mitochondrial Myopathies (Mitochondrial Myopathy)
10/2017
1Ulcer
01/2017
1Genetic Translocation (Chromosomal Translocation)
01/2016
1Neoplasm Metastasis (Metastasis)
01/2016
1Adenocarcinoma of Lung
01/2016
1Colorectal Neoplasms (Colorectal Cancer)
01/2016

Drug/Important Bio-Agent (IBA)

4RNA (Ribonucleic Acid)IBA
03/2022 - 10/2017
2cyclic diadenosine phosphateIBA
12/2023 - 01/2022
2Pathogen-Associated Molecular Pattern MoleculesIBA
12/2023 - 01/2022
2VaccinesIBA
10/2023 - 03/2022
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
2InterferonsIBA
01/2022 - 01/2022
2Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2021 - 10/2017
1JHU083IBA
05/2024
1ProdrugsIBA
05/2024
1Glutamine (L-Glutamine)FDA Link
05/2024
1CarcinogensIBA
01/2022
1enfortumab vedotinIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Fumarate Hydratase (Fumarase)IBA
01/2021
1trastuzumab deruxtecanIBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1Adenosine Monophosphate (AMP)IBA
02/2020
1prosteinIBA
01/2020
1Photosensitizing Agents (Photosensitizers)IBA
01/2019
1Coloring Agents (Dyes)IBA
10/2018
1HLA-A Antigens (HLA-A)IBA
10/2018
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
07/2018
1Mucin-1 (CA 15-3 Antigen)IBA
01/2018
1Chemotactic FactorsIBA
01/2018
1Cadherins (E-Cadherin)IBA
01/2018
1Immunoglobulin G (IgG)IBA
01/2017
1Prostate-Specific Antigen (Semenogelase)IBA
01/2017
1Anaplastic Lymphoma KinaseIBA
01/2016
1ceritinibIBA
01/2016

Therapy/Procedure

5Therapeutics
01/2022 - 10/2017
2Neoadjuvant Therapy
01/2024 - 01/2017
1Drug Therapy (Chemotherapy)
01/2024
1Radiotherapy
01/2022
1Transurethral Resection of Bladder
02/2020
1Cystectomy
02/2020
1Sex Reassignment Surgery
01/2018
1Transurethral Resection of Prostate (TURP)
01/2018
1Cautery
01/2018
1Chemoradiotherapy
01/2017
1Cytoreduction Surgical Procedures
01/2017